Literature DB >> 16272522

Detection of a bla(SHV) extended-spectrum {beta}-lactamase in Salmonella enterica serovar Newport MDR-AmpC.

Shelley C Rankin1, Jean M Whichard, Kevin Joyce, Lynn Stephens, Kathleen O'shea, Helen Aceto, Donald S Munro, Charles E Benson.   

Abstract

Salmonella enterica serovar Newport MDR-AmpC expressing TEM-1b and extended-spectrum beta-lactamase SHV-12 was isolated from affected animals during an outbreak of salmonellosis that led to a 3-month closure of one of the largest equine hospitals in the United States.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16272522      PMCID： PMC1287834          DOI： 10.1128/JCM.43.11.5792-5793.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  20 in total

1.  Evolution of extended-spectrum beta-lactam resistance (SHV-8) in a strain of Escherichia coli during multiple episodes of bacteremia.

Authors:  J K Rasheed; C Jay; B Metchock; F Berkowitz; L Weigel; J Crellin; C Steward; B Hill; A A Medeiros; F C Tenover
Journal:  Antimicrob Agents Chemother       Date:  1997-03       Impact factor: 5.191

2.  Survey and molecular genetics of SHV beta-lactamases in Enterobacteriaceae in Switzerland: two novel enzymes, SHV-11 and SHV-12.

Authors:  M T Nüesch-Inderbinen; F H Kayser; H Hächler
Journal:  Antimicrob Agents Chemother       Date:  1997-05       Impact factor: 5.191

3.  Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC beta-lactamase, and the foss of an outer membrane protein.

Authors:  P A Bradford; C Urban; N Mariano; S J Projan; J J Rahal; K Bush
Journal:  Antimicrob Agents Chemother       Date:  1997-03       Impact factor: 5.191

4.  beta-Lactamases among extended-spectrum beta-lactamase (ESBL)-resistant Salmonella from poultry, poultry products and human patients in The Netherlands.

Authors:  Henrik Hasman; Dik Mevius; Kees Veldman; Inger Olesen; Frank M Aarestrup
Journal:  J Antimicrob Chemother       Date:  2005-06-07       Impact factor: 5.790

5.  Predominance and genetic diversity of community- and hospital-acquired CTX-M extended-spectrum beta-lactamases in York, UK.

Authors:  C J Munday; G M Whitehead; N J Todd; M Campbell; P M Hawkey
Journal:  J Antimicrob Chemother       Date:  2004-08-04       Impact factor: 5.790

6.  DNA sequence analysis of regions surrounding blaCMY-2 from multiple Salmonella plasmid backbones.

Authors:  W P Giles; A K Benson; M E Olson; R W Hutkins; J M Whichard; P L Winokur; P D Fey
Journal:  Antimicrob Agents Chemother       Date:  2004-08       Impact factor: 5.191

7.  Pediatric infection due to multiresistant Salmonella enterica serotype Infantis in Honduras.

Authors:  Ernesto Liebana; Miranda Batchelor; Carmen Torres; Laura Briñas; Luis A Lagos; Baha Abdalhamid; Nancy D Hanson; Jaime Martinez-Urtaza
Journal:  J Clin Microbiol       Date:  2004-10       Impact factor: 5.948

8.  Emergence of multidrug-resistant Salmonella enterica serotype Newport infections resistant to expanded-spectrum cephalosporins in the United States.

Authors:  Amita Gupta; John Fontana; Colleen Crowe; Barbara Bolstorff; Alison Stout; Susan Van Duyne; Mike P Hoekstra; Jean M Whichard; Timothy J Barrett; Frederick J Angulo
Journal:  J Infect Dis       Date:  2003-11-18       Impact factor: 5.226

9.  SHV-12-like extended-spectrum-beta-lactamase-producing strains of Salmonella enterica serotypes Babelsberg and Enteritidis isolated in France among infants adopted from Mali.

Authors:  François-Xavier Weill; Marie Demartin; Didier Tandé; Emmanuelle Espié; Ignace Rakotoarivony; Patrick A D Grimont
Journal:  J Clin Microbiol       Date:  2004-06       Impact factor: 5.948

10.  Imipenem resistance in a Salmonella clinical strain due to plasmid-mediated class A carbapenemase KPC-2.

Authors:  Vivi Miriagou; Leonidas S Tzouvelekis; Shannon Rossiter; Eva Tzelepi; Frederick J Angulo; Jean M Whichard
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191
View more
  7 in total

1.  Isolation of Salmonella enterica serotype newport from a partly ruptured splenic abscess in a traveler returning from Zanzibar.

Authors:  Dennis Tappe; Andreas Müller; Heinz-Jakob Langen; Matthias Frosch; August Stich
Journal:  J Clin Microbiol       Date:  2007-07-18       Impact factor: 5.948

2.  First detection of CTX-M and SHV extended-spectrum beta-lactamases in Escherichia coli urinary tract isolates from dogs and cats in the United States.

Authors:  Alexandra O'Keefe; Tabitha A Hutton; Dieter M Schifferli; Shelley C Rankin
Journal:  Antimicrob Agents Chemother       Date:  2010-05-17       Impact factor: 5.191

3.  Survival of Salmonella enterica serovar Newport in manure and manure-amended soils.

Authors:  Youwen You; Shelley C Rankin; Helen W Aceto; Charles E Benson; John D Toth; Zhengxia Dou
Journal:  Appl Environ Microbiol       Date:  2006-09       Impact factor: 4.792

4.  Inc A/C plasmids are prevalent in multidrug-resistant Salmonella enterica isolates.

Authors:  Rebecca L Lindsey; Paula J Fedorka-Cray; Jonathan G Frye; Richard J Meinersmann
Journal:  Appl Environ Microbiol       Date:  2009-01-30       Impact factor: 4.792

5.  beta-Lactam resistance in salmonella strains isolated from retail meats in the United States by the National Antimicrobial Resistance Monitoring System between 2002 and 2006.

Authors:  S Zhao; K Blickenstaff; A Glenn; S L Ayers; S L Friedman; J W Abbott; P F McDermott
Journal:  Appl Environ Microbiol       Date:  2009-10-23       Impact factor: 4.792

6.  Detection of mcr-9-harbouring ESBL-producing Salmonella Newport isolated from an outbreak in a large-animal teaching hospital in the USA.

Authors:  Mohammed Elbediwi; Hang Pan; Xiao Zhou; Shelley C Rankin; Dieter M Schifferli; Min Yue
Journal:  J Antimicrob Chemother       Date:  2021-03-12       Impact factor: 5.790

7.  Multiple Food-Animal-Borne Route in Transmission of Antibiotic-Resistant Salmonella Newport to Humans.

Authors:  Hang Pan; Narayan Paudyal; Xiaoliang Li; Weihuan Fang; Min Yue
Journal:  Front Microbiol       Date:  2018-01-23       Impact factor: 5.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.